Skip to content

Clinical trials

Recruiting Myelodysplastic Syndromes trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Recruiting Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20191
20202
20211
20221
20231
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda3
AstraZeneca1
BeOne Medicines1
Celgene1
GlaxoSmithKline1
Heinrich-Heine University, Duesseldorf1
Institut de Recherches Internationales Servier1
Swedish Orphan Biovitrum1
Taiho Oncology, Inc.1
University Hospital Freiburg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes13
Anemia3
Leukemia, Myeloid, Acute3
Leukemia, Myelomonocytic, Chronic2
Anemia, Refractory, with Excess of Blasts1
Cytopenia1
Hematologic Diseases1
Hematologic Neoplasms1
Leukemia1
Leukemia, Myelomonocytic, Juvenile1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.